Skip to content

Haemonetics HAE PEG ratio

PEG ratio at other companies

Abbott logo
AbbottABT
0.1×-2.8×
Boston Scientific logo
Boston ScientificBSX
0.3×-4.8×
Medtronic logo
MedtronicMDT
7.3×+6.4×
LivaNova logo
LivaNovaLIVN
0.2×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
3.9×+3.2×
LeMaitre Vascular logo
LeMaitre VascularLMAT
-0.2×

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on the most recent quarter.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's PEG ratio?
Haemonetics (HAE) reported PEG ratio of 0.6× in Q4 2025.
How has Haemonetics's PEG ratio changed year-over-year?
Haemonetics's PEG ratio decreased by 94.4% year-over-year, from 10.9× to 0.6×.
What is the long-term trend for Haemonetics's PEG ratio?
Over 3 years (2021 to 2025), Haemonetics's PEG ratio has grown at a -71.1% compound annual growth rate (CAGR), from 18.6× to 0.4×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.